)
Visual
earnings real time
Optiscan Imaging (OIL) investor relations material
Optiscan Imaging Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status Update summary4 Dec, 2025
Transformation and Commercialization Strategy
Transitioning from OEM to private label manufacturer to control product destiny and market access.
Strategic focus on developing and commercializing proprietary hardware and software for clinical and veterinary applications.
Building internal capabilities, upskilling staff, and expanding manufacturing to support regulatory and commercial goals.
Partnerships with leading institutions like Mayo Clinic and Australian Clinical Labs to accelerate clinical data collection and regulatory submissions.
Cash injections from R&D tax refunds and capital raises support ongoing transformation and clinical programs.
Product and Clinical Development Milestones
Launched and progressed multiple devices: InForm (pathology), InView (surgical), InSpecta (veterinary), and telepathology software.
Initiated and advanced clinical studies in GI imaging, breast cancer, and head and neck cancer, with key milestones achieved.
Veterinary device InSpecta on track for U.S. launch in mid-2026; human devices InView and InForm targeting 2027 launch post-FDA clearance.
Telepathology and AI-based software tools in development, with clinical deployment planned after hardware launches.
Flexible GI endomicroscope in R&D, aiming for broad compatibility and market access.
Financial and Operational Status
Raised AUD 17.75 million in 2023, with about AUD 19 million in cash to fund 18–24 months of operations and clinical programs.
At least half of recent capital raise allocated to clinical and regulatory studies, dossier preparation, and certification.
Expansion of commercial team, especially in the U.S., to support upcoming product launches and market entry.
Revenue model includes hardware sales, SaaS for telepathology and AI, and consumables, targeting ARR of $5–10 million plus $4–8 million from disposables.
GI flexible device: How does open system expand market?
Post-trial funds: What are key investment priorities?
Vet device: How ensure post-clearance compliance?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Optiscan Imaging earnings date
H1 202625 Feb, 2026
Next Optiscan Imaging earnings date
H1 202625 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Optiscan Imaging Limited is an Australian medical technology company focused on the development and commercialization of innovative imaging systems. The company specializes in real-time, high-resolution confocal endomicroscopes designed for use in clinical settings, particularly for applications in cancer diagnosis and surgical procedures. Optiscan’s imaging technology enables healthcare professionals to view cellular structures and tissues in vivo, supporting more accurate diagnostics and minimally invasive procedures. Optiscan Imaging Limited is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage